Tag: Dr. Reddy’s Laboratories
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.
Featured Article
Why manufacturers are embracing AI-powered smart supply chains
Manufacturers are facing an increasingly volatile environment, where rapid changes in demand, supply chain disruptions, and continued cost pressures are transforming the way products are planned, made, and delivered.
